Scientists dive deep into the genetics of pulmonary hypertension to redefine the disease

NCT ID NCT02980887

First seen Nov 17, 2025 · Last updated May 20, 2026 · Updated 24 times

Summary

This study aims to better understand pulmonary hypertension by analyzing the genes, molecules, and cells of 1,195 participants with various heart and lung conditions. The goal is to create more precise definitions of the disease and identify new biomarkers. This research does not test a new treatment but seeks to improve future diagnosis and care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Brigham and Women's Hospital

    Boston, Massachusetts, 02115, United States

  • Johns Hopkins University School of Medicine

    Baltimore, Maryland, 21287, United States

  • Mayo Clinic

    Rochester, Minnesota, 55905, United States

  • New York Medical College

    Valhalla, New York, 10595, United States

  • University of Arizona Health Sciences Center

    Tucson, Arizona, 85721, United States

  • Vanderbilt University Medical Center

    Nashville, Tennessee, 37232, United States

  • Weill Cornell Medicine

    New York, New York, 10065, United States

Conditions

Explore the condition pages connected to this study.